Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Boston Scientific TAXUS results

This article was originally published in The Gray Sheet

Executive Summary

European TAXUS IV 30-day safety data of complete study population and 12-month follow-up from 61-patient TAXUS I study presented Nov. 18 at American Heart Association meeting in Chicago. Results for the primary endpoint of cumulative major adverse cardiac events from the FilterWire EX embolic protection FIRE trial will be released later that day at the firm's evening symposium...



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts